**Al-Jahdari 2006** Al-Jahdari WS, Yamamoto K, Hiraoka H, Nakamura K, Goto F, Horiuchi R. Prediction of total propofol clearance based on enzyme activities in microsomes from human kidney and liver. Eur J Clin Pharmacol. 2006 Jul;62(7):527-33. doi: 10.1007/s00228-006-0130-2. Epub 2006 Jun 9.

**Court 2005** Court M, Isoform‐Selective Probe Substrates for *In Vitro* Studies of Human UDP‐Glucuronosyltransferases. Methods Enzymol. 2005;400:104-16. doi: 10.1016/S0076-6879(05)00007-8.

**Drugbank.ca** (https://www.drugbank.ca/drugs/DB00818)

**Gepts 1987** Gepts E, Camu F, Cockshott ID, Douglas EJ. Disposition of propofol administered as constant rate intravenous infusions in humans. Anesth Analg. 1987 Dec;66(12):1256-63.

**Kuepfer 2016** Kuepfer L, Niederalt C, Wendl T, Schlender JF, Willmann S, Lippert J, Block M, Eissing T, Teutonico D. Applied Concepts in PBPK Modeling: How to Build a PBPK/PD Model.CPT Pharmacometrics Syst Pharmacol. 2016 Oct;5(10):516-531. doi: 10.1002/psp4.12134. Epub 2016 Oct 19. 

**Mazoit 1999** Mazoit JX, Samii K. Binding of propofol to blood components: implications for pharmacokinetics and for pharmacodynamics. Br J Clin Pharmacol, 47 (1999), pp. 35-42.

**Oda 2001** Oda Y, Hamaoka N, Hiroi T, Imaoka S, Hase I, Tanaka K, Funae Y, Ishizaki T, Asada A. Involvement of human liver cytochrome P4502B6 in the metabolism of propofol. Br J Clin Pharmacol. 2001 Mar; 51(3): 281–285. doi: 10.1046/j.1365-2125.2001.00344.x

**PK-Sim Ontogeny Database Version 7.3** (https://github.com/Open-Systems-Pharmacology/OSPSuite.Documentation/blob/38cf71b384cfc25cfa0ce4d2f3addfd32757e13b/PK-Sim%20Ontogeny%20Database%20Version%207.3.pdf)

**Restrepo 2009** Restrepo JG, Garcia-Martín E, Martínez C, Agúndez JAG. Polymorphic drug metabolism in anaesthesia. Curr Drug Metab. 2009 Mar;10(3):236-46. doi: 10.2174/138920009787846305.

**Schlender 2016** Schlender JF, Meyer M, Thelen K, Krauss M, Willmann S, Eissing T, Jaehde U. Development of a Whole-Body Physiologically Based Pharmacokinetic Approach to Assess the Pharmacokinetics of Drugs in Elderly Individuals. Clin Pharmacokinet. 2016 Dec;55(12):1573-1589. 

**Schnider 1998** Schnider TW, Minto CF, Gambus PL, Andresen C, Goodale DB, Shafer SL, Youngs EJ. Anesthesiology. 1998 May;88(5):1170-82. doi: 10.1097/00000542-199805000-00006.

**Struys 2007** Struys MMRF, Coppens MJ, De Neve N, Mortier EP, Doufas AG, Van Bocxlaer JFP, Shafer SL. Anesthesiology. 2007 Sep;107(3):386-96. doi: 10.1097/01.anes.0000278902.15505.f8.

**Takizawa 2005** Takizawa D, Hiraoka H, Goto F, Yamamoto K, Horiuchi R. Human kidneys play an important role in the elimination of propofol. Anesthesiology. 2005 Feb;102(2):327-30. doi: 10.1097/00000542-200502000-00014.